Authors:
ROSTAING L
IZOPET J
MOUSSION F
ALRIC L
VERDIER D
THAT HT
DUFFAUT M
DURAND D
PUEL J
SUC JM
Citation: L. Rostaing et al., HCV RNA CLEARANCE BY HEMODIALYSIS-PATIENT S WITH AND WITHOUT HGV HGBV-C INFECTION AFTER ALPHA-INTERFERON-THERAPY/, Nephrologie, 18(7), 1997, pp. 281-286
Authors:
IZOPET J
ROSTAING L
MOUSSION F
ALRIC L
DUBOIS M
THAT HT
PAYEN JL
DUFFAUT M
DURAND D
SUE JM
PUEL J
Citation: J. Izopet et al., HIGH-RATE OF HEPATITIS-C VIRUS CLEARANCE IN HEMODIALYSIS-PATIENTS AFTER INTERFERON-ALPHA THERAPY, The Journal of infectious diseases, 176(6), 1997, pp. 1614-1617
Authors:
IZOPET J
ROSTAING L
THAT HT
VERNIER I
MOUSSION F
ROSSIGNOL ME
DUPRE C
HENRY S
GIROLAMI JP
ICART J
DURAND D
PUEL J
Citation: J. Izopet et al., INCIDENCE OF HCV INFECTION IN HEMODIALYSIS UNITS WITH OR WITHOUT PATIENTS ISOLATION, Journal of the American Society of Nephrology, 6(3), 1995, pp. 537-537
Authors:
IZOPET J
ROSTAING L
MOUSSION F
THAT HT
PAYEN JL
SAYADA C
DUFFAUT M
GIROLAMI JP
DURAND D
PUEL J
PUPAN CHU
RANGUEIL CHU
Citation: J. Izopet et al., LONG-TERM VIROLOGICAL RESPONSE AFTER ALPHA-INTERFERON THERAPY IN HCV-POSITIVE HEMODIALYSIS-PATIENTS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 537-537
Authors:
CANAUD B
BENNHOLD I
DELONS S
DONNADIEU P
FORET M
FRANZ H
HOERL W
KOESTERS W
KREUSSER W
THAT HT
POLITOBOULOUX C
MION C
POISSON D
Citation: B. Canaud et al., WHAT IS THE OPTIMUM FREQUENCY OF ADMINISTRATION OF RHUEPO FOR CORRECTING ANEMIA IN HEMODIALYSIS-PATIENTS, Dialysis & transplantation, 24(6), 1995, pp. 306
Authors:
LLOVERAS JJ
LARRUE V
DELISLE MB
TACK I
ICART J
DUPRE C
THAT HT
DURAND D
SUC JM
Citation: Jj. Lloveras et al., GUILLAIN-BARRE-SYNDROME ASSOCIATED WITH C YTOMEGALOVIRUS-INFECTION AFTER RENAL-TRANSPLANTATION, La Presse medicale, 23(21), 1994, pp. 976-978